20 The large dsDNA virus HSV-1 is often considered to be genetically stable, however it is known 21 to rapidly evolve in response to strong selective pressures such as antiviral drug treatment. Deep 22 sequencing analysis has revealed that clinical and laboratory isolates of this virus exist as 23 populations that contain a mixture of minor alleles or variants, similar to many RNA viruses.
142 representative of the original HSV-1 F strain that was previously described to contain 143 approximately 3% syncytial plaques, as well as an unexpected UL13 frameshift mutation 144 (Figure 1) [26, 27] . This variability in plaque phenotype was an early indication that the Mixed 145 population was genetically heterogeneous. The F-Purified population (subsequently "Purified") 146 was derived from the Mixed population by three rounds of sequential plaque purification of a 147 non-syncytial variant [26, 27] . It displays a homogenous, non-syncytial plaque morphology 148 (Figure 1) . Each viral population was used to infect a separate monolayer of Vero cells at a MOI 149 of 0.01. Following lysis of the cell monolayer, the resulting sample was harvested, titered, and 150 examined for plaque morphology. This procedure is referred to as a passage for the purposes of 151 these experiments. The titered viral stock from the first passage was used to infect the next p.8 152 monolayer of Vero cells at the same low MOI, and this process was repeated for 10 sequential 153 passages. The viral population at each passage was also deep-sequenced (Figure 1) . Low MOI 154 conditions were chosen to allow for multiple rounds of replication in each passage, enabling the 155 most fit viral genotypes to expand in the population.
156
Over the course of ten sequential passages, we noticed dramatic changes in plaque 157 morphology in the Mixed population (Figure 1, Figure 2A ). However, we did not observe 158 substantial changes in viral titer across the ten passages in either viral population (Figure 2B) . At 159 passage 0 (P0), we observed ~3% syncytial plaques in the Mixed population. The frequency of 160 syncytial plaque-forming viruses in the population increased steadily with each passage, until 161 nearly 100% syncytial plaques were observed at passage 10 (P10). The conversion from 162 predominantly non-syncytial to syncytial plaques in the population was observed in three 163 independent lineages of the passaging experiment (Figure 2A) . In contrast, the Purified 164 population did not contain any syncytial plaques at P0, and the syncytial plaque phenotype was 165 not acquired over the course of ten passages. Using plaque morphology as a visual marker of 166 genetic diversity, these results suggested that the more genetically diverse Mixed population was 167 better able to adapt or evolve over the course of this experiment.
168
Few Changes in Consensus Genomes were Observed over 10 Passages 169 Because each independent Mixed lineage displayed similar changes in plaque 170 morphology, we chose one lineage each for Mixed and Purified viral populations and used high-171 throughput sequencing (HTS) to examine the viral genetic diversity at each passage. Full-length, 172 consensus genomes were assembled for each passage using a de novo assembly pipeline [26] .
174 entire viral population into the most common nucleotide observed at each location in the genome 175 [14] . Therefore, these genomes represent the consensus of the sequencing reads that were aligned 176 to each position. We found that the consensus genomes were similar overall from passage to 177 passage within the same lineage (i.e. Mixed vs. Purified), which enabled curation and 178 improvement of the assembled sequences. The high percent identity of a full-genome alignment 179 derived from each set of 10 passages is presented in Figure 2C . 226 were unable to identify any such high-confidence variants of this type in the Purified population 227 lineage. While we cannot disregard the minor variants that sporadically appear in both of these 228 viral populations, the lack of observed consistency from passage to passage makes these sporadic 229 minor variants more difficult to conclusively identify, especially when they occurred in the 230 aforementioned repetitive regions. These data suggest that when HSV-1 has a more diverse 231 starting genetic population (i.e. the Mixed population), it is more able to change in response to 232 the pressures of a given environment.
233

Frequency of Minor Variants May Reveal Selective Pressures In Vitro 234
We next investigated the types of minor variants that were present and how their 235 frequencies changed over sequential passages of the viral population. We found that most of the 236 high-confidence minor variants were missense mutations, though examples of non-coding and 237 synonymous or silent mutations were also identified ( Table 1) . Many minor variants increased as 238 a percentage of the population over sequential passage, while others seemed to reach an 239 equilibrium level of standing variation ( Figure 5A and Table 1 ). We did not observe any minor 240 variants that were clearly linked as a haplotype, in that their frequencies did not change in 241 parallel. Accordingly, we treated each minor variant an individual contributor to the population. p.12
243 selective advantage under these experimental conditions. This outcome is most clearly illustrated 244 by the syncytia-inducing variants in UL27 (glycoprotein B, gB), which match previously 245 described spontaneous mutations observed in this and other strains of HSV-1 [35] [36] [37] [38] .
246
Other minor variants appeared to reach an equilibrium in frequency within the viral 247 population, which is a more difficult pattern to interpret. We found a particularly intriguing 248 example of equilibration within the population with minor variants present in the UL13 gene.
249 UL13 is the HSV-1 encoded representative of the Conserved Herpesvirus-encoded Protein 250 Kinases (CHPK). UL13 kinase activity is dispensable in vitro [39], but it is required for axonal 251 transport in vivo [40] . The kinase domain of this enzyme is located in the C-terminal end of the 252 protein, with the crucial catalytic lysine located at amino acid 176 ( Figure 5B ) [41] [42] [43] . We 253 identified two distinct minor variants that would cause premature termination of UL13 and 254 would not be anticipated to have any kinase activity. We refer to these variants as W30*stop, a 255 missense mutation, and Frameshift Stop (or S118[F.S.]), an indel in a homopolymer ( Figure 5B 256 and 5C). The Frameshift Stop insertion was present in a slight majority of the initial population 257 (51%) and it rapidly declined in frequency over sequential passages. However, the W30*stop 258 variant increased in frequency in the population over the same passages. In combination, these 259 two presumably defective variants of the UL13 gene added up to a stable level of ~30% of the 260 viral population. Thus, we observed a tolerance and/or a selection of UL13 variants that would 261 presumably produce inactive kinases (Figure 5B and 5C).
262
The presence of defective UL13 variants in HSV-1 populations is not unique to the F 263 strain. In a recent publication by our group that compared a cultured clinical isolate to direct-264 from-patient swab-based sequencing of a genital HSV-1 lesion, we detected UL13 minor 265 variants only in the cultured material [12] . We extended this investigation to two newly isolated 266 clinical genital HSV-1 isolates, and likewise detected UL13-inactivating minor variants in these 267 cultured populations. These variants rose in frequency over the initial passages in vitro, reaching 268 substantially higher levels, in fewer passages, than the rate of change observed in the Mixed 269 population (Figure 5D ). It is as yet unknown why these viral populations would maintain 270 standing variation in the UL13 gene, and/or favor the inactivation of UL13 in Vero cell culture.
271
Syncytial Phenotype is Favored in Vero Cells
272
While the role of UL13 in Vero cell culture remains unclear, it is clear that the syncytial 273 plaque phenotype is favored under these conditions. Three independent lineages of Mixed viral 274 populations became dominated by syncytial variants (Figure 2 ) under these experimental 275 conditions, and the selective advantage of syncytia formation in Vero cell culture has been 276 previously reported [44] . However, it is known that a syncytial phenotype can be caused by 277 multiple independent genetic variants, and we can infer that each syncytial variant could have a 278 different effect on viral fitness. We were able to identify two previously described syncytial 
289
These data suggest that each of these syncytial variants in gB occurred and proliferated 290 independently. Therefore, we sought to address whether or not these variants ever co-occurred 291 on the same stretch of DNA. The proximity of these variants in the genome enabled us to 292 identify a number of sequencing reads, each corresponding to one physical piece of DNA, that 293 spanned both minor variant loci in gB (UL27) (Figure 6A) . We detected each minor variant 294 within this subset of reads at a frequency that was comparable to the overall frequency of the 295 variant in the population (Figure 6B-6C ). We found that each variant occurred independently.
296 Across all reads spanning these loci in 10 passages, we found only 6 instances of these minor 297 variants co-occurring in a single sequence read. We interpret these results as an indication that 298 the syncytial phenotype, rather than any individual genetic variant, is being selected for under 299 these conditions of Vero cell culture.
300
To test this hypothesis, we conducted a competition experiment in which two purified 301 populations of HSV-1 were mixed in defined ratios and allowed to replicate under the same 302 conditions as the original in vitro evolution experiment. We made use of a previously described 303 syncytial clone of the F-Mixed population [27] , which carries the R858H syncytial variant in gB, 304 as well as the same F-Purified population as was used in Figure 1 . These purified populations of 305 uniformly syncytial or uniformly non-syncytial viruses were competed in defined ratios, where 306 one or the other plaque phenotype was dominant at the start (50:1, 5:1, 1:5, and 1:50, Syncytial :
307 Non-Syncytial). We also included one case of equal starting input (1:1, Syncytial : Non-308 Syncytial). As in the original in vitro evolution experiment, we found that viruses with a 309 syncytial phenotype took over the viral population (Figure 7) . The starting ratio influenced the 310 rate of syncytial virus takeover, as shown by the slopes of each curve in Figure 7 . However, all 311 ratio mixtures were predominantly syncytial by P10. In this study, we examined the evolution of HSV-1 during viral replication in vitro. We 328 sequentially passaged either a mixed or a purified population of HSV-1 in Vero cell culture, and 329 we quantified the outcome both in terms of observed phenotypes and in genomic changes over 330 time. These approaches enabled us to monitor how the viral population changed from passage to 331 passage, to detect potentially advantageous viral genotypes and/or phenotypes under these 332 conditions, and to examine how a diverse versus a homogeneous pool of viral genomes impacted 333 the subsequent genetic drift of each viral population. We found that the more diverse ("Mixed") 334 viral population was much more prone to change during passaging, with a syncytial plaque 335 phenotype emerging as an advantageous trait under these Vero cell culture conditions. In 336 addition to the genetic variants associated with syncytia formation, we observed the proliferation 337 of a multitude of other genetic variants that may also confer a selective advantage in Vero cell 338 culture conditions. Because Vero cell culture is the main methodology behind HSV-1 and HSV-2 339 propagation, both in experimental and diagnostic lab settings, these data provide key insights on 340 the need to detect and understand viral evolution and selection in vitro. This is especially critical 341 if the goal is to use laboratory observations to improve our understanding of viral population 342 dynamics in actual human infections.
343
From these experiments, we were able to gain a number of useful insights for HSV-1, 344 which may well extend to other herpesviruses and large DNA viruses. First, these experiments 345 emphasized the contributions of standing variation and genetic diversity to HSV-1 evolution. 378 detected here that rise in frequency over sequential passages (e.g. Figure 5A ). The rapid rise in 379 frequency of UL13 variants observed in early passages of two clinical isolates (Figure 5D) 380 suggests that the initial passages of new clinical isolates may serve as a useful screening 381 approach to detect which of these minor variants are most impactful for viral fitness in vitro -i.e.
382 those most frequently observed and/or rapidly selected in newly cultured clinical isolates.
383 Intriguingly, both the UL13 and UL14 variants observed here were also detected in the initial 384 culture passages of the genital HSV-1 isolate v29 [12] .
385
These data lay the foundation for a number of subsequent explorations using similar 386 approaches. First, as mentioned above, it is a goal of our lab and others to model the dynamics of 387 HSV-1 infection that occur in human patients in a controlled setting of laboratory culture. Table 1 for full list of minor variants). Each 746 variant would cause a change in the translated protein, whether through premature stop (UL13 
